Eliem Therapeutics, Inc. Profile Avatar - Palmy Investing

Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central ner…

Biotechnology
US, Redmond [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of ELYM's Analysis
CIK: 1768446 CUSIP: 28658R106 ISIN: US28658R1068 LEI: - UEI: -
Secondary Listings
ELYM has no secondary listings inside our databases.